A final important finding of this study is the identification of a large deletion encompassing CFH, CFHR3, and CFHR1 in a IC-MPGN patient in cluster 2 with low C3 and FH serum levels. This evidence concerns the gene FH and primary membranoproliferative glomerulonephritis.